• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSS2300075 西妥昔单抗注射液 cetuximab Injection Biological Products(3.3) New Drug Application 2023-09-09 Sichuan Kelun-Biotech Biopharmaceutical Co Ltd view
JYSB2300113 西妥昔单抗注射液 cetuximab Injection Biological Products Supplementary Application 2023-06-26 view
CXSS2300012 CMAB009注射液 cetuximab Injection Biological Products(2.4) New Drug Application 2023-03-14 Taizhou Maibotaike Pharmaceutical Co Ltd view
JYSB2300024 西妥昔单抗注射液 cetuximab Injection Biological Products Supplementary Application 2023-02-11 view
JYSB2300012 西妥昔单抗注射液 cetuximab Injection Biological Products Supplementary Application 2023-01-20 view
JYSZ2200023 西妥昔单抗注射液 cetuximab Injection Biological Products License Renew 2022-06-14 view
JXSS2101029 西妥昔单抗注射液 cetuximab Injection Biological Products(3.1) Import Drug Application 2021-11-03 view
JYSF2100001 西妥昔单抗注射液 cetuximab Injection Biological Products Supplementary Application 2021-01-08 默克制药(江苏)有限公司 Moke Pharmaceutical Manufacturing (Jiangsu) Co Ltd Filed 2021-01-22 view
JYSB2000677 西妥昔单抗注射液 cetuximab Injection Biological Products Supplementary Application 2020-12-28 默克雪兰诺有限公司 Merck Serono Co Ltd In Review 2020-12-25 view
JYSB2000421 西妥昔单抗注射液 cetuximab Injection Biological Products Supplementary Application 2020-08-28 默克雪兰诺有限公司 Merck Serono Co Ltd Filed 2020-09-09 view
JYSB2000335 西妥昔单抗注射液 cetuximab Injection Biological Products Supplementary Application 2020-07-10 默克雪兰诺有限公司 Merck Serono Co Ltd Certificate Issued 2020-09-29 view
JYSB2000174 西妥昔单抗注射液 cetuximab Injection Biological Products Supplementary Application 2020-05-14 默克雪兰诺有限公司 Merck Serono Co Ltd Certificate Issued 2020-06-04 view
JYSB2000175 西妥昔单抗注射液 cetuximab Injection Biological Products Supplementary Application 2020-05-07 默克雪兰诺有限公司 Merck Serono Co Ltd Filed 2020-05-19 view
JYSB1900326 西妥昔单抗注射液 cetuximab Injection Biological Products Supplementary Application 2019-12-09 默克雪兰诺有限公司 Merck Serono Co Ltd Certificate Issued 2020-02-14 view
JYSB1900253 西妥昔单抗注射液 cetuximab Injection Biological Products Supplementary Application 2019-09-21 默克雪兰诺有限公司 Merck Serono Co Ltd Certificate Issued 2019-11-27 view
JTS1900019 西妥昔单抗注射液 cetuximab Injection Biological Products Disposable Import Drug Application 2019-05-27 Merck KGaA Merck KGaA Certificate Issued 2019-06-17 view
JXSS1900014 西妥昔单抗注射液 cetuximab Injection Biological Products Import Drug Application 2019-04-15 德国默克公司 Merck KGaA Certificate Issued 2020-02-27 view
JYSB1800303 西妥昔单抗注射液 cetuximab Injection Biological Products Supplementary Application 2019-01-14 德国默克公司 Merck KGaA Certificate Issued 2020-03-26 view
JYSB1800298 西妥昔单抗注射液 cetuximab Injection Biological Products Supplementary Application 2018-12-17 德国默克公司 Merck KGaA Filed 2018-12-24 view
JYSB1800198 西妥昔单抗注射液 cetuximab Injection Biological Products Supplementary Application 2018-10-17 德国默克公司 Merck KGaA Certificate Issued 2019-08-19 view